Ładuje się......
The Subcontinental Surge
Biotech is following big pharma to India, where R&D costs are a fraction of those in the U.S. India itself is working hard to make it happen. Ultimately, this could reduce the price of biotech therapies. But what about India’s reputation for disregarding intellectual property rights?
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioCommunications LLC
2004
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564301/ https://ncbi.nlm.nih.gov/pubmed/23393438 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|